NewsFDA Issues Alert Regarding SARS-CoV-2 Mutation to Clinical Laboratory StaffU.S. Food and Drug Administration | January12th,2021 If mutations occur in the part of the virus’s genome assessed by a test, the mutations can cause false negative results
Thought LeadershipBattling COVID-19 and Bracing for the Flu: How Molecular Tests Can HelpSherry Dunbar, PhD, MBA | September9th,2020 Rapid, multiplex molecular tests will give labs flexibility and scalability as they plan for the upcoming flu season
NewsPreliminary Results of Nationwide SARS-CoV-2 Molecular Testing Survey ReleasedAssociation for Molecular Pathology | May28th,2020 More than 100 clinical laboratory professionals across the US provided feedback on COVID-19 diagnostic testing environment
NewsBeware of False Negatives in COVID-19 Diagnostic Testing Johns Hopkins Medicine | May27th,2020 When it comes to accuracy, timing of molecular tests is critical
TechnologyMolecular Tools for Tuberculosis TestingRaeesa Gupte, PhD | May1st,2020 Novel diagnostic approaches for accurate, comprehensive, and accelerated results
Product NewsAn Instrument-Free Molecular Diagnostic Test for COVID-19Sense Biodetection Limited | April17th,2020 Pioneering new class of diagnostic product will transform fight against pandemic
NewsNew NGS Technique Dramatically Shortens Diagnosis of SepsisElsevier | March6th,2020 Availability of results within five to six hours of blood draw allows faster and more precise intervention
TechnologyTrends in Point-Of-Care TestingNeeta Ratanghayra, M.Pharm | November30th,2019 Point-of-care technologies hold tremendous potential to improve health care delivery